(Q36902779)

17 August 2017

1 reference

title

Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome (English)

1 reference

17 August 2017

1 reference

1 reference

Po Sing Leung

1

1 reference

17 August 2017

Marc de Gasparo

series ordinal

2

1 reference

17 August 2017

publication date

1 January 2006

1 reference

Journal of the cardiometabolic syndrome

17 August 2017

published in

1 reference

17 August 2017

volume

1

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

197-203

1 reference

Obesity, regional body fat distribution, and the metabolic syndrome in older men and women

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Anti-diabetic effect of blockade of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Inflammation: the link between insulin resistance, obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Adipose tissue as an endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Endothelial dysfunction, inflammation and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Leptin suppression of insulin secretion and gene expression in human pancreatic islets: implications for the development of adipogenic diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Inflammation and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Angiotensin blockade prevents type 2 diabetes by formation of fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Cardiac arrhythmias: the possible role of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

The effects of valsartan on insulin sensitivity in patients with primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2006.05460.X

10.1111/J.1559-4564.2006.05460.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference